Gregory Resch was actively involved as phage expert in the first European multicenter phase 1/2 clinical trial of phage therapy conducted according to standards of good practices. Results of safety and efficacy of an anti-Pseudomonas aeruginosa phage cocktail were reported in burn patients with infected wounds.